All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Effect of vatinoxan co-administered with medetomidine on intraocular pressure and pupil diameter in healthy dogs

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16170%2F25%3A43882278" target="_blank" >RIV/62157124:16170/25:43882278 - isvavai.cz</a>

  • Result on the web

    <a href="http://chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://vetmed.agriculturejournals.cz/pdfs/vet/2025/12/01.pdf" target="_blank" >http://chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://vetmed.agriculturejournals.cz/pdfs/vet/2025/12/01.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.17221/47/2025-VETMED" target="_blank" >10.17221/47/2025-VETMED</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Effect of vatinoxan co-administered with medetomidine on intraocular pressure and pupil diameter in healthy dogs

  • Original language description

    Medetomidine, an alpha-2 adrenoreceptor agonist, is used for sedation. This study aimed to determine the influence of the alpha-2 adrenoreceptor antagonist vatinoxan, co-administered with medetomidine, on healthy dogs’ intraocular pressure (IOP) and pupil diameter (PD). A prospective, randomised, masked clinical study was performed. A total of 40 conscious dogs were allocated to one of two groups: medetomidine 0.01 mg/kg with vatinoxan 0.2 mg/kg intravenously (MV-group, n = 20) or medetomidine 0.01 mg/kg intravenously (M-group, n = 20). The IOP, PD, heart rate, and mean arterial pressure were measured prior to baseline and 5, 10, and 20 min after drug administration. Data were analysed using one- and two-way repeated measures ANOVA or their non-parametric equivalents (P &lt; 0.05). No significant differences in IOP within or between groups were recorded. In the MV-group, PD remained unchanged compared to baseline. In the M-group, PD significantly (P = 0.007, P &lt; 0.001, P &lt; 0.001) decreased compared to baseline at all observation times. PD was significantly (P = 0.010, P &lt; 0.001, P &lt; 0.001) smaller in the M-group at all observation times compared to the MV-group. Vatinoxan co-administered with medetomidine, as well as medetomidine alone, did not significantly influence IOP. Vatinoxan with medetomidine did not affect PD, while medetomidine alone significantly reduced it.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    40301 - Veterinary science

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Veterinární medicína

  • ISSN

    0375-8427

  • e-ISSN

    1805-9392

  • Volume of the periodical

    70

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    5

  • Pages from-to

    427-431

  • UT code for WoS article

    001654806700001

  • EID of the result in the Scopus database